GHRS

GH Research (GHRS)

About GH Research (GHRS)

GH Research Plc is a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients with psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

Details

Daily high

$21.77

Daily low

$20.75

Price at open

$20.97

52 Week High

$24.66

52 Week Low

$9.46

Market cap

1.3B

Dividend yield

0.00%

Volume

161,072

Avg. volume

286,131

P/E ratio

-27.11

GH Research News